Skip to search formSkip to main contentSkip to account menu

Etosuximida Faes

Known as: Faes Brand of Ethosuximide, Faes, Etosuximida 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Ethosuximide

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2003
Review
2003
Lerisetron. FAES.
Lerisetron is a 5-hydroxytryptamine3 receptor antagonist under development by FAES Farma for the potential treatment of emesis… 
1977
1977
Efficacy Testing of Valproic Acid Compared to Ethosuximide in Monkey Model: I. Dosage Regimen Design in the Presence of Diurnal Oscillations
Valproic acid (VPA) and ethosuximide (ESM) were administered by intravenous infusion at a constant rate to 12 chronically… 
1959
1959
"Nombres y cosas de las calles de Oviedo" de J. Tolivar Faes
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)